B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CCNE2

MOLECULAR TARGET

cyclin E2

UniProt: O96020NCBI Gene: 91343 compounds

CCNE2 (cyclin E2) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CCNE2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Adenosine Triphosphate0.691
2alsterpaullone0.691
3kenpaullone0.691

About CCNE2 as a Drug Target

CCNE2 (cyclin E2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented CCNE2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CCNE2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.